Systematic verification of upstream regulators of a computable cellular proliferation network model on non-diseased lung cells using a dedicated dataset

Bioinformatics and Biology Insights

Volumn 7, Issue , 2013, Pages 217-230

  Belcastro, Vincenzo ^a   Poussin, Carine ^a   Gebel, Stephan ^b   Mathis, Carole ^a   Schlage, Walter K ^b   Lichtner, Rosemarie B ^b   Quadt Humme, Sibille ^b   Wagner, Sandra ^a   Hoeng, Julia ^a   Peitsch, Manuel C ^a  

^a PHILIP MORRIS PRODUCTS S A   (Switzerland)

^b Philip Morris Research Laboratories GmbH   (Germany)

Author keywords

Biological network model; Cell proliferation; Reverse causal reasoning

Indexed keywords

ADULT; ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL PROLIFERATION NETWORK MODEL; CONTROLLED STUDY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; HUMAN; HUMAN CELL; MATHEMATICAL MODEL; QUALITATIVE ANALYSIS; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; VALIDATION STUDY;

EID: 84880838585     PISSN: None     EISSN: 11779322     Source Type: Journal    
DOI: 10.4137/BBI.S12167     Document Type: Article

References (39)

1. Hoeng J, Deehan R, Pratt D, et al. A network-based approach to quantifying the impact of biologically active substances. Drug Discov Today. 2012; 17(9-10):413-8.
2. Mahadevan B, Snyder RD, Waters MD, et al. Genetic toxicology in the 21st century: reflections and future directions. Environ Mol Mutagen. 2011;52(5):339-354.
3. Stephens ML, Barrow C, Andersen ME, et al. Accelerating the development of 21st-century toxicology: outcome of a Human Toxicology Project Consortium workshop. Toxicol Sci. 2012;125(2):327-334.
4. Westra JW, Schlage WK, Frushour BP, et al. Construction of a computable cell proliferation network focused on non-diseased lung cells. BMC Syst Biol. 2011;5:105.
5. OpenBEL Consortium. Available at: http://www.openbel.org. Accessed Jun 21, 2013.
6. Selventa. Reverse Causal Reasoning. Available at: http://selventa.com/sites/selventa.drupalgardens.com/files/RCR%20Whitepaper.pdf. Accessed Jun 21, 2013.
7. Martin F, Thomson TM, Sewer A, et al. Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks. BMC Syst Biol. 2012;6:54.
8. Fields WR, Leonard RM, Odom PS, Nordskog BK, Ogden MW, Doolittle DJ. Gene expression in normal human bronchial epithelial (NHBE) cells following in vitro exposure to cigarette smoke condensate. Toxicol Sci. 2005;86(1):84-91.
9. Fischer BM, Zheng S, Fan R, Voynow JA. Neutrophil elastase inhibition of cell cycle progression in airway epithelial cells in vitro is mediated by p27kip1. Am J Physiol Lung Cell Mol Physiol. 2007;293(3):L762-768.
10. Booth BW, Sandifer T, Martin EL, Martin LD. IL-13-induced proliferation of airway epithelial cells: mediation by intracellular growth factor mobilization and ADAM17. Respir Res. 2007;8:51.
11. Enomoto Y, Orihara K, Takamasu T, et al. Tissue remodeling induced by hypersecreted epidermal growth factor and amphiregulin in the airway after an acute asthma attack. J Allergy Clin Immunol. 2009;124(5):913-20.
12. Shinkai M, Tamaoki J, Kobayashi H, et al. Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and delays cell growth via extracellular signal-regulated protein kinase suppression. Antimicrob Agents Chemother. 2006;50(5):1738-1744.
13. Fry DW, Harvey PJ, Keller PR, et al. Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts. Mol Cancer Ther. 2004;3(11):1427-1438.
14. Finn RS, Dering J, Conklin D, et al. PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro. Breast Cancer Res. 2009;11(5):R77.
15. Ramsey MR, Krishnamurthy J, Pei XH, et al. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Cancer Res. 2007;67(10):4732-4741.
16. Saab R, Bills JL, Miceli AP, et al. Pharmacologic inhibition of cyclindependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Mol Cancer Ther. 2006;5(5): 1299-1308.
17. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545-15550.
18. Liberzon A, Subramanian A, Pinchback R, Thorvaldsdóttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27(12):1739-1740.
19. Selventa. Selventa Technology Platform. 2013; Available at: http://www.selventa.com. Accessed Jun 21, 2013.
20. Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005;24(50):7455-7464.
21. Desai LP, Aryal AM, Ceacareanu B, Hassid A, Waters CM. RhoA and Rac1 are both required for efficient wound closure of airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004;287(6):L1134-1144.
22. Kolyada AY, Riley KN, Herman IM, Rho GT Pase signaling modulates cell shape and contractile phenotype in an isoactin-specific manner. Am J Physiol, Cell Physiol. 2003;285(5):C1116-1121.
23. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE, Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res. 1994;54(13): 3391-3395.
24. Liang J, Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle. 2003;2(4):336-342.
25. Carracedo A, Pandolfi PP. The PTEN-PI3K pathway: of feedbacks and cross-talks. Oncogene. 2008;27(41):5527-5541.
26. Guziolowski C, Kittas A, Dittmann F, Grabe N. Automatic generation of causal networks linking growth factor stimuli to functional cell state changes. FEBS J. 2012;279(18):3462-3474.
27. Tentner AR, Lee MJ, Ostheimer GJ, Samson LD, Lauffenburger DA, Yaffe MB. Combined experimental and computational analysis of DNA damage signaling reveals context-dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress. Mol Syst Biol. 2012;8:568.
28. Karr JR, Sanghvi JC, Macklin DN, et al. A whole-cell computational model predicts phenotype from genotype. Cell. 2012;150(2):389-401.
29. Belcastro V, Siciliano V, Gregoretti F, et al. Transcriptional gene network inference from a massive dataset elucidates transcriptome organization and gene function. Nucleic Acids Res. 2011;39(20):8677-8688.
30. Caron E, Ghosh S, Matsuoka Y, et al. A comprehensive map of the mTOR signaling network. Mol Syst Biol. 2010;6:453.
31. Matsuoka Y, Ghosh S, Kikuchi N, Kitano H. Payao: a community platform for SBML pathway model curation. Bioinformatics. 2010;26(10):1381-1383.
32. Schlage WK, Westra JW, Gebel S, et al. A computable cellular stress network model for non-diseased pulmonary and cardiovascular tissue. BMC Syst Biol. 2011;5:168.
33. Gebel S, Lichtner RB, Frushour B, et al. Construction of a computable network model for DNA damage, autophagy, cell death, and senescence. Bioinform Biol Insights. 2013;7:97-117.
34. Park JS, Schlage WK, Frushour BP, et al. Construction of a Computable Network Model of Tissue Repair and Angiogenesis in the Lung. J Clinic Toxicol. 2013:S12-002.
35. Westra JW, Schlage WK, Hengstermann A, et al. A modular cell-type focused inflammatory process network model for non-diseased pulmonary tissue. Bioinform Biol Insights. 2013;7:167-192.
36. Background adjustment using sequence information. gcrma. Available at: http://bioconductor.org/packages/2.2/bioc/html/gcrma.html. Accessed Jun 21, 2013.
37. Molecular Signatures Database. Canonical pathway subset of the C2 collection. Available at: http://www.broadinstitute.org/gsea/msigdb/index.jsp. Accessed Jun 21, 2013.
38. Bodenhofer U, Kothmeier A, Hochreiter S. APCluster: an R package for affinity propagation clustering. Bioinformatics. 2011;27(17):2463-2464.
39. Frey BJ, Dueck D. Clustering by passing messages between data points. Science. 2007;315(5814):972-976.